Also known as cold agglutinin disease (CAD), this type of hemolytic ... For example, hemolysis triggered by cold temperatures may cause cold fingers and toes, which may turn red, purple, or ...

Having already been on a winding journey, Enjaymo, which Sanofi acquired through a 2018 buyout of Bioverativ, is now headed ...

As Sanofi continues to clean out its medicine chest, Italy’s Recordati is getting in on the action. | Recordati is floating ...

characterized by episodic whitening and bluish discoloration of the fingers due to cold or stress. This symptom often appears ...

The results, to be published in the next edition of the British Journal of Cardiology, could provide an early warning of potential heart disease. By studying boys' hands, doctors could spot those ...

Enjaymo treats cold agglutinin disease, a condition in which the immune system attacks red blood cells and causes them to rupture. This process happens at cold temperatures, giving the disease its ...

Additionally, peripheral artery disease caused by diabetes can block or slow the blood flow to your lower extremities, making them cold. Here are some easy ways to warm up your fingers and toes ...

Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.

In cold AIHA, also called cold agglutinin disease, antibodies are active at very cold temperatures (0º to 4°C or 32º to 39ºF). Alloimmune hemolytic anemia occurs when your body makes ...

Whether or not the cold-agglutinin titer has a relation to a patient's antibody response or to his degree of immunity to subsequent infection by the causative agent of this disease, it seems ...

Italian pharma group Recordati (RECI.MI), opens new tab said on Friday it would buy from Sanofi (SASY.PA), opens new tab the global rights to a drug used to treat cold agglutinin disease (CAD), a ...

Biotech company Regeneron Pharmaceuticals lost a bid on Friday to be held immune from allegations that it misused a patented protein while testing a COVID-19 treatment. UK to consider bill to ...